Ignite Creation Date:
2025-12-25 @ 2:54 AM
Ignite Modification Date:
2026-04-18 @ 7:19 AM
Study NCT ID:
NCT06877533
Status:
TERMINATED
Last Update Posted:
2025-08-12
First Post:
2025-03-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 as Monotherapy and in Combination With Pembrolizumab or Other Anticancer Treatments in Participants With Advanced Solid Tumors
Sponsor:
iTeos Belgium SA
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TRM-010
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None